Duvelisib with Docetaxel for Patients with Anti–PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma
2024 · Clinical Cancer Research · 6 citations
https://doi.org/10.1158/1078-0432.ccr-24-2262
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
8
Citations
1
h-index
0
i10-index
L. B. Oakley is an academic researcher. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Head and Neck Cancer Studies & Cancer Diagnosis and Treatment. The author has an h-index of 1, co-authored 19 publications.
Click to start Chat